找回密码
 注册

微信登录,快人一步

QQ登录

只需一步,快速开始

查看: 1174|回复: 6

看到一篇胡教授团队发表的文章

[复制链接]
发表于 2017-8-4 11:00 | 显示全部楼层 |阅读模式

马上注册登录,享用更多感控资源,助你轻松入门。

您需要 登录 才可以下载或查看,没有账号?注册 |

×
International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009

摘要:The results of a surveillance study conducted by the International Nosocomial Infection Control Consortium (INICC) from January 2004 through December 2009 in 422 intensive care units (ICUs) of 36 countries in Latin America, Asia, Africa, and Europe are reported. During the 6-year study period, using Centers for Disease Control and Prevention (CDC) National Healthcare Safety Network (NHSN; formerly the National Nosocomial Infection Surveillance system [NNIS]) definitions for device-associated health care-associated infections, we gathered prospective data from 313,008 patients hospitalized in the consortium’s ICUs for an aggregate of 2,194,897 ICU bed-days. Despite the fact that the use of devices in the developing countries’ ICUs was remarkably similar to that reported in US ICUs in the CDC’s NHSN, rates of device-associated nosocomial infection were significantly higher in the ICUs of the INICC hospitals; the pooled rate of central line-associated bloodstream infection in the INICC ICUs of 6.8 per 1,000 central line-days was more than 3-fold higher than the 2.0 per 1,000 central line-days reported in comparable US ICUs. The overall rate of ventilator-associated pneumonia also was far higher (15.8 vs 3.3 per 1,000 ventilator-days), as was the rate of catheter-associated urinary tract infection (6.3 vs. 3.3 per 1,000 catheter-days). Notably, the frequencies of resistance of Pseudomonas aeruginosa isolates to imipenem (47.2% vs 23.0%), Klebsiella pneumoniae isolates to ceftazidime (76.3% vs 27.1%), Escherichia coli isolates to ceftazidime (66.7% vs 8.1%), Staphylococcus aureus isolates to methicillin (84.4% vs 56.8%), were also higher in the consortium’s ICUs, and the crude unadjusted excess mortalities of device-related infections ranged from 7.3% (for catheter-associated urinary tract infection) to 15.2% (for ventilator-associated pneumonia).
回复

使用道具 举报

发表于 2017-8-4 11:18 | 显示全部楼层
一看36个countries就觉得高大上!!!
回复

使用道具 举报

发表于 2017-8-4 12:27 | 显示全部楼层
这论文离我们好遥远                           
回复

使用道具 举报

发表于 2017-8-4 16:17 | 显示全部楼层
英语太难了~
回复

使用道具 举报

发表于 2017-8-4 16:23 | 显示全部楼层
国际医院感染控制联盟(INICC)的报告,对2004-2009年36个国家的数据进行汇总。由国际医院感染控制联盟进行了监测研究结果(INICC)从2004年1月到2009年12月的422个重症监护病房(ICU)的36个国家在拉丁美洲的美国、亚洲、非洲、欧洲报道。在6年的研究期间,采用美国疾病控制和预防中心(CDC)国家医疗保健安全网络(NHSN;原国家医院感染监测系统[系统])相关的卫生保健相关感染设备的定义,我们从313008例患者在ICU住院的财团的2194897 ICU床日总聚集的前瞻性数据。尽管事实上,设备在发展中国家的ICU的使用非常类似的报道在美国的CDC NHSN ICU、装置相关感染率分别为:根据医院的加护病房的显著升高;合并率中央导管相关血流感染的ICU 6.8根据每1000中央线的日子是3倍以上,高于2每1000天报中心线可比我们加护病房。呼吸机相关性肺炎的总体比率也高得多(15.8比3.3每1000呼吸机日),导管相关尿路感染率(每1000个导管日6.3对3.3)。值得注意的是,对铜绿假单胞菌耐药菌株频率对亚胺培南(47.2% vs 23%),Klebsiella pneumoniae株对头孢他啶(76.3% vs 27.1%),大肠埃希菌对头孢他啶(66.7% vs 8.1%),金黄色葡萄球菌菌株对甲氧西林(84.4% vs 56.8%),也高于该财团的加护病房,和粗调整过剩装置相关感染的死亡率为7.3%(导尿管相关尿路感染)到15.2%(呼吸机相关性肺炎)。
回复

使用道具 举报

发表于 2017-8-4 17:06 | 显示全部楼层
有时间下载看看学习一下,谢谢分享
回复

使用道具 举报

发表于 2017-8-7 08:35 | 显示全部楼层
有必要下载原文看看了
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 注册 |

本版积分规则

快速回复 返回顶部 返回列表